glp-1 7-36 Glucagon-like peptide 1 (7-36)amide | C151H229N41O46 | CID 16132173 Human GLP1 (7-36) ELISA Kit

GLP-1 (Glucagon-Like Peptide-1) medications, such as semaglutide, have gained significant attention for their role in weight loss and managing type 2 diabetes

(The best results were seen in those who were overweight

Following GLP-1 deprescription, patients weight did not significantly increase at 6 or 12 months post deprescription, compared to many well-known drug trials (in red) where patients regain up to two thirds of weight loss after discontinuing the drug

27% of patients achieved more than 15% weight loss compared to 0% on placebo

Tirzepatide has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions and weight loss programs, and due to it's unique property, may result in greater effects on body weight, glucose and lipids

GoalBMI Wellness provides physician-supervised online medical weight loss consultations for eligible patients